Junwei Zeng Selected Research

MRS 2211

1/2018

Activation of spinal dorsal horn P2Y13 receptors can promote the expression of IL-1β and IL-6 in rats with diabetic neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junwei Zeng Research Topics

Disease

6	Pain (Aches) 01/2023 - 09/2017
6	Hyperalgesia 01/2023 - 09/2017
5	Neuralgia (Stump Neuralgia) 01/2022 - 09/2017
2	Neoplasms (Cancer) 01/2023 - 11/2012
2	Hypersensitivity (Allergy) 01/2023 - 04/2022
2	Seizures (Absence Seizure) 12/2020 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 12/2016
2	IGA Glomerulonephritis (IGA Nephropathy) 10/2013 - 11/2012
2	Virus Diseases (Viral Diseases) 08/2010 - 04/2009
2	Infections 08/2010 - 12/2007
1	Infarction (Infarctions) 01/2024
1	Carcinoma (Carcinomatosis) 01/2023
1	Congenital Disorders of Glycosylation 01/2023
1	Status Epilepticus (Complex Partial Status Epilepticus) 12/2020
1	COVID-19 07/2020
1	Epilepsy (Aura) 01/2020
1	Fibrosis (Cirrhosis) 10/2019
1	Gliosis 10/2019
1	Wounds and Injuries (Trauma) 10/2019
1	Cicatrix (Scar) 10/2019
1	Peripheral Nerve Injuries 09/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2016
1	Colitis 12/2016
1	Tn Syndrome 10/2013
1	Carcinogenesis 10/2013
1	Human Influenza (Influenza) 04/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2017
3	ICI D2788IBA 01/2023 - 01/2021
2	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 01/2023 - 04/2022
2	Tn antigenIBA 01/2023 - 11/2012
2	AntigensIBA 01/2023 - 10/2013
2	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 10/2013
2	Cyclic NucleotidesIBA 01/2023 - 01/2021
2	Purinergic P2X ReceptorsIBA 04/2022 - 02/2018
2	Glutamic Acid (Glutamate)FDA Link 12/2020 - 01/2018
2	SB 203580IBA 12/2020 - 01/2018
2	CytokinesIBA 01/2018 - 12/2007
2	Immunoglobulin G (IgG)IBA 08/2010 - 04/2009
1	triphenyltetrazoliumIBA 01/2024
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2023
1	AntibodiesIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Purinergic P2X3 ReceptorsIBA 04/2022
1	Connexin 43 (Connexin43)IBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021
1	Streptozocin (Streptozotocin)FDA Link 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 12/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2020
1	RNA (Ribonucleic Acid)IBA 07/2020
1	AMPA Receptors (AMPA Receptor)IBA 01/2020
1	Kainic Acid (Kainate)IBA 01/2020
1	Pentylenetetrazole (Metrazol)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2019
1	NeurocanIBA 10/2019
1	Minocycline (Cyclops)FDA LinkGeneric 01/2019
1	Uridine Diphosphate (UDP)IBA 10/2018
1	N,N''- 1,4- butanediylbis(N'- (3- isothiocyanatophenyl))thioureaIBA 10/2018
1	purinoceptor P2Y6IBA 10/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2018
1	InterleukinsIBA 01/2018
1	AcidsIBA 01/2018
1	MRS 2211IBA 01/2018
1	Excitatory Amino AcidsIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	AM 1241IBA 09/2017
1	Purinergic Receptors (Receptors, Purine)IBA 09/2017
1	adenosine 5'-O-(2-thiodiphosphate) (ADP-S)IBA 09/2017
1	Messenger RNA (mRNA)IBA 09/2017
1	CannabinoidsIBA 09/2017
1	CB2 Cannabinoid ReceptorIBA 09/2017
1	Phenobarbital (Luminal)FDA Link 12/2016
1	MucinsIBA 12/2016
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 10/2013
1	Immunoglobulin A (IgA)IBA 08/2010
1	beta-D-Galactoside alpha 2-6-SialyltransferaseIBA 04/2009
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2009
1	Galactose (Galactopyranose)FDA LinkGeneric 04/2009
1	LectinsIBA 04/2009
1	Immunoglobulin M (IgM)IBA 04/2009
1	Antiviral Agents (Antivirals)IBA 04/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2007

Therapy/Procedure

3	Spinal Injections 04/2022 - 09/2017